1. Home
  2. QDEL vs PAHC Comparison

QDEL vs PAHC Comparison

Compare QDEL & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuidelOrtho Corporation

QDEL

QuidelOrtho Corporation

N/A

Current Price

$19.94

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

N/A

Current Price

$48.49

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QDEL
PAHC
Founded
1979
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
QDEL
PAHC
Price
$19.94
$48.49
Analyst Decision
Hold
Hold
Analyst Count
4
3
Target Price
$32.75
$34.33
AVG Volume (30 Days)
1.3M
232.7K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
1.00%
EPS Growth
45.35
1883.33
EPS
N/A
1.32
Revenue
$2,730,200,000.00
$833,350,000.00
Revenue This Year
$3.51
$17.03
Revenue Next Year
$3.86
$3.82
P/E Ratio
N/A
$36.22
Revenue Growth
N/A
4.12
52 Week Low
$19.50
$16.16
52 Week High
$38.46
$56.30

Technical Indicators

Market Signals
Indicator
QDEL
PAHC
Relative Strength Index (RSI) 29.71 47.64
Support Level $19.50 $37.09
Resistance Level $30.65 $56.14
Average True Range (ATR) 1.28 2.27
MACD -0.10 -0.94
Stochastic Oscillator 15.25 26.88

Price Performance

Historical Comparison
QDEL
PAHC

About QDEL QuidelOrtho Corporation

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: